Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

625.05INR
17 Apr 2014
Price Change (% chg)

Rs11.20 (+1.82%)
Prev Close
Rs613.85
Open
Rs614.50
Day's High
Rs626.00
Day's Low
Rs614.10
Volume
2,033,985
Avg. Vol
2,698,012
52-wk High
Rs653.35
52-wk Low
Rs441.85

SUN.NS

Chart for SUN.NS

About

Sun Pharmaceutical Industries Limited is an international specialty pharma company. The Company manufactures and markets pharmaceutical formulations as branded generics, as well as generics in India, the United states and several other markets across the world. The Company’s business is divided into four segments: US Generics,... (more)

Overall

Beta: 0.38
Market Cap (Mil.): Rs1,271,384.00
Shares Outstanding (Mil.): 2,071.16
Dividend: 2.50
Yield (%): 0.41

Financials

  SUN.NS Industry Sector
P/E (TTM): 48.74 32.99 33.14
EPS (TTM): 12.60 -- --
ROI: -- 19.69 18.95
ROE: -- 20.38 19.71
Search Stocks

UPDATE 1-Market Chatter-Corporate finance press digest

(Adds item on Freshpet LLC, El Pollo Loco Inc, Sun Pharmaceutical Industries Ltd, Go Daddy Group)

10 Apr 2014

SEBI examines Sun, Ranbaxy merger trading - source

MUMBAI - The Securities and Exchange Board of India (SEBI) will ask Ranbaxy Laboratories and Sun Pharmaceutical Industries for more information about their planned $3.2 billion merger and seek trading data from stock exchanges after shares in Ranbaxy surged in the run-up to the deal, a senior source at the regulator said on Wednesday.

09 Apr 2014

India's Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in U.S.: sources

MUMBAI - India's Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States, after completing a $3.2 billion takeover of its loss-making rival by the year end, sources with direct knowledge of the matter said.

09 Apr 2014

SEBI to ask stock exchanges for trading data on Ranbaxy shares

MUMBAI - Securities and Exchange Board of India (SEBI) will ask the country's stock exchanges for trading details on Ranbaxy Laboratories Ltd and Sun Pharmaceutical shares before the companies announced a merger on Monday, a senior source at the regulator said on Wednesday.

09 Apr 2014

Sensex up over 350 points, hits record high of 22,740

MUMBAI - The BSE Sensex rose to a record high on Monday, surpassing its previous all-time highs hit last week as Sun Pharmaceutical Industries surged on broker upgrades after it agreed on Monday to acquire Ranbaxy Laboratories in a $3.2 billion deal.

09 Apr 2014

India regulator to ask stock exchanges for trading data in Ranbaxy shares

MUMBAI, April 9 - India's market regulator will ask the country's stock exchanges for trading details on Ranbaxy Laboratories Ltd and Sun Pharmaceutical shares before the companies announced a merger on Monday, a senior source at the regulator said on Wednesday.

09 Apr 2014

Sun Pharma, lenders drive Indian shares to life-highs

MUMBAI, April 9 - Indian shares hit record highs on Wednesday, surpassing previous all-time highs hit just last week as Sun Pharmaceutical Industries surged on broker upgrades after it agreed to acquire Ranbaxy Laboratories in a $3.2 billion deal.

09 Apr 2014

Indian shares rally to record highs; Sun Pharma surges

MUMBAI, April 9 - Indian shares hit record highs on Wednesday, surpassing previous all-time highs hit just last week as Sun Pharmaceutical Industries surged on broker upgrades after it agreed to acquire Ranbaxy Laboratories in a $3.2 billion deal.

09 Apr 2014

Indian brokers association to ask regulator to investigate Ranbaxy trades

MUMBAI, April 9 - The president of an Indian brokerage association is planning to formally request that India's market regulator investigate trading in Ranbaxy Laboratories Ltd shares in the days leading up to its acquisition by Sun Pharmaceutical Industries Ltd.

09 Apr 2014

Sun Pharma up as brokers welcome Ranbaxy purchase

Reuters Market Eye - Shares in Sun Pharmaceutical Industries gain as much as 7.95 percent, adding to their 2.9 percent rise on Monday, as brokers upgrade the stock after Sun agreed to buy Ranbaxy Laboratories Ltd for $3.2 billion.

09 Apr 2014

Earnings vs. Estimates

Search Stocks